Arizona's Prop 207 Passes to Legalize Recreational Cannabis in Arizona While CBD Life Sciences Inc. Is in Talks to Lease a Farm

SCOTTSDALE, AZ / ACCESSWIRE / December 1, 2020 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announced today that cannabis recreational use has finally come to Arizona following the overwhelming passage of Arizona's Proposition 207 - the measure that legalizes recreational use of cannabis throughout the state. Coupled with the President-elect's promise to decriminalize cannabis on a federal level, LBC Bioscience Inc. believes that this coming year is shaping up to be its best year yet.

"We anticipated recreational use happening in Arizona for the past 2 years, and the timing of the AZ bill's passage couldn't have worked out better for our company," said Lisa Nelson, LBC Bioscience Inc President and CEO. Furthermore "We have also identified several exciting farm sites in the Wickenburg area that could allow us to take advantage of Prop 207 and continue our expansion".

The Company now plans to ask our State's Congressional Delegation to consider federally legalizing cannabis, even if the bill included the ability of states who are not willing to go along to exempt themselves from the regulation if they so desired - similar to the legislation that passed to end prohibition. The company has previously mentioned a desire to expand as much as possible over the past few months despite the ongoing pandemic.

LBC Bioscience Inc. is well stocked with some very high-quality CBD offerings - all at very reasonable prices with its Holiday Specials. Check out LBC Bioscience Inc's newest product offerings including its: 100mg CBD Bath Bombs in a variety of scents with Holiday Scents coming within the next few weeks. 1500 MG Premium Berry Drops, 100MG CBD Tablets and our tasty CBD Gumballs. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.

Why Shop LBC Bioscience?

  • Free Shipping on All Orders for the Holidays
  • Large Selection of Products (over 50 items and growing)
  • 100% USA Made Products "organic & kosher"
  • 30% off on all products through the Holidays using code "LBC30"

LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.

Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc's Main Website at

About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including: CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and purchased on the Company's website at

Ten Associates LLC
: Thomas E. Nelson
Telephone: (480)326-8577

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking

SOURCE: CBD Life Sciences Inc.

View source version on

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.